Arafat Tfayli
- Oncology top 5%
- Global Cancer Incidence and Screening 9
- HER2/EGFR in Cancer Research 9
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 7
- Cancer Research top 10%
- Breast Cancer Treatment Studies 12
- Cancer Genomics and Diagnostics 6
- Pharmacology top 5%
-
- Lung Cancer Treatments and Mutations 18
- Lung Cancer Diagnosis and Treatment 11
- Co-authors
- Ali ShamseddineSally TemrazRachel Abou MradNathalie K. ZgheibZeina NahlehDeborah MukherjiHazem AssiAhmad Awada
- Cited by
- OncologyCancer ResearchPharmacology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (6 papers)PLoS ONE (1 paper)
- Partner nations
- LebanonUnited StatesBelgium
In The Last Decade
Arafat Tfayli
86 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 115
- Oncology 522
- Cancer Research 277
- Pharmacology 94
- Complementary and alternative medicine 64
- Pulmonary and Respiratory Medicine 229
Countries citing papers authored by Arafat Tfayli
This map shows the geographic impact of Arafat Tfayli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arafat Tfayli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arafat Tfayli more than expected).
Fields of papers citing papers by Arafat Tfayli
This network shows the impact of papers produced by Arafat Tfayli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arafat Tfayli. The network helps show where Arafat Tfayli may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Arafat Tfayli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 5 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 41 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 21 | |
| 10 | 2019 | 0 | |
| 11 | 2018 | 15 | |
| 12 | 2018 | 22 | |
| 13 | 2018 | 5 | |
| 14 | 2018 | 1 | |
| 15 | BARRIERS TO MAMMOGRAPHY SCREENING: HOW TO OVERCOME THEM | 2015 | 5 |
| 16 | 2015 | 1 | |
| 17 | Face Validity of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FACT- B) into Formal Arabic | 2014 | 8 |
| 18 | 2013 | 0 | |
| 19 | 2011 | 39 | |
| 20 | Pseudoneutropenia from EDTA Leukoagglutination | 2010 | 1 |
About Arafat Tfayli
Arafat Tfayli is a scholar working on Oncology, Cancer Research and Microbiology, having authored 95 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Breast Cancer Treatment Studies (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Global Cancer Incidence and Screening (9 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (7 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (522 citations), Cancer Research (277 citations) and Pharmacology (94 citations). Arafat Tfayli has collaborated with scholars based in Lebanon, United States and Belgium. Frequent co-authors include Ali Shamseddine, Sally Temraz, Rachel Abou Mrad, Nathalie K. Zgheib, Zeina Nahleh, Deborah Mukherji, Hazem Assi, Ahmad Awada, Nagi S. El Saghir and Ehab Saad Aldin. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.